Top

Category: Industry


Industry, Vaccines

COVID vaccines help Pfizer, Moderna reign supreme reputation-wise, but they’re a double-edged sword for J&J and AZ

January 20, 2022

Via: FiercePharma

Pfizer and Moderna are now two of the leading pharma companies in the U.S. when it comes to public image, thanks to their COVID vaccines. On the flip side, vaccine rivals J&J and AstraZeneca have seen their reputations plummet. This […]


Cell and Gene Therapy, Industry

New Gene Therapy May Potentially Treat Severe Form of Epilepsy

January 20, 2022

Via: Genetic Engineering and Biotechnology News

Scientists from the University of Virginia (UVA) School of Medicine describe in a study involving mouse models how a newly developed gene therapy can treat Dravet syndrome, a severe form of epilepsy, and potentially prolong survival for people with the […]


Cell and Gene Therapy, Industry

CBM and Penn Strike $100M Cell & Gene Therapy Deal

January 20, 2022

Via: Contract Pharma

The Center for Breakthrough Medicines (CBM) and the University of Pennsylvania’s Gene Therapy Program (GTP) have signed a landmark collaboration agreement, to combine Penn’s knowledge and expertise in the development of Gene therapies with CBM’s manufacturing capacity and singular focus […]


Industry, Vaccines

mRNA COVID-19 vaccines safe for pregnant women, finds EMA review

January 19, 2022

Via: European Pharmaceutical Review

According to the European Medicines Agency (EMA)’s COVID-19 task force (ETF), a growing body of evidence suggests that messenger RNA (mRNA) COVID-19 vaccines do not cause pregnancy complications for expectant mothers and their babies. The ETF undertook a detailed review […]


Industry, Vaccines

WHO Says Worst of Pandemic Could Ease This Year if Vaccine Inequities Erased

January 19, 2022

Via: Drugs.com

If COVID-19 vaccines and medicines are shared equally worldwide, the pandemic could ease this year, a top World Health Organization official said Tuesday. However, if wealthier countries don’t share their resources with poorer countries, there will continue to be high […]


Biotech, Industry

How CRO venture capital relationships can help biotech fundraising

January 18, 2022

Via: Biopharma Dive

Developing drugs is a capital-intensive activity, and never more so than when a biotech company wants to move from preclinical development to more expensive clinical trials. Early on, there are often angel investments and/or academic or government grants, but the […]


Industry, Vaccines

Gates Foundation supports HIV and malaria research

January 14, 2022

Via: Pharma Times

The new commitment from the Bill & Melinda Gates Foundation supports the development of Vir Biotech’s ‘vaccinal antibody’ technology, a significant tool in combatting global infectious diseases. Vir’s antibody research initiative aims for a functional cure for HIV and for […]


Industry, Vaccines

As Omicron Surges, Effort to Vaccinate Young Children Stalls

January 14, 2022

Via: Kaiser Health News

Two months after Pfizer’s covid vaccine was authorized for children ages 5 to 11, just 27% have received at least one shot, according to Jan. 12 data from the Centers for Disease Control and Prevention. Only 18%, or 5 million […]


Biotech, Industry

COVID Pandemic Prompts Renewed Interest in Biotech Startups

January 12, 2022

Via: Biopharm International

The momentum of biotech and biopharma companies is on the rise in anticipation of a new wave of emerging therapies moving through the industry’s development pipeline. In addition, the COVID-19 pandemic highlighted the importance of companies that can react quickly […]


Cell and Gene Therapy, Industry

Pfizer expands into gene editing with Beam research deal

January 10, 2022

Via: Biopharma Dive

Last summer, Mikael Dolsten, head of research and development at Pfizer and the company’s top scientist, was thinking of new uses for the messenger RNA technology the pharmaceutical giant had developed so effectively for its coronavirus vaccine. The drugmaker already […]


Industry, Vaccines

FDA Shortens Time to Booster After Moderna Vaccine to 5 Months

January 7, 2022

Via: Drugs.com

Citing the rapid spread of the Omicron variant and the need for protection against it, U.S. federal health officials are shortening the recommended time between the second dose of the Moderna vaccine and a booster shot from six months down […]


Biotech, Industry

Merck leans into AI with $610M in biobucks for Absci drug discovery pact

January 7, 2022

Via: FierceBiotech

Merck is taking a deep dive into complex proteins with the help of artificial-intelligence-powered drug discovery company Absci. The two companies have signed a research collaboration for up to three targets in a deal worth up to $610 million in […]